BiotechTube
Home/Disc Medicine/Will Savage, MD, PhD
WS

Will Savage, MD, PhD

Chief Medical Officer

Disc Medicine

Therapeutic Areas

HematologyRare Diseases

Disc Medicine Pipeline

DrugIndicationPhase
BitopertinErythropoietic Protoporphyria (EPP) & X-Linked Protoporphyria (XLP)Phase 3
DISC-0974Anemia of Myelofibrosis (MF)Phase 2
DISC-3405Polycythemia VeraPhase 2b
DISC-0998Anemia Associated with Inflammatory DiseasesPreclinical

Leadership Team at Disc Medicine

JQ
John Quisel, JD, PhD
Chief Executive Officer
JF
Jean Franchi
Chief Financial Officer
JY
Jonathan Yu
Chief Operating Officer
PS
Pamela Stephenson, MPH
Chief Commercial Officer
SC
Steve Caffé, MD
Chief Regulatory Officer
RR
Rahul Rajan Kaushik, PhD
Chief Technical Officer
View full Disc Medicine profile